HIV Diagnostics: Key Disease Management Role Spells OpportunityDecision ResourcesSeptember 21, 2005 19 Pages - SKU: DECR1212119 |
| HIV stands out as a highly lucrative and expanding market for diagnostics because of the close integration of diagnostics in day-to-day disease diagnosis, management, and drug selection. The greatest changes and improvements in HIV diagnostics will be in the area of monitoring disease progression in individual patients. Such tests will help physicians optimally manage the disease and minimize drug failures and will ultimately have the potential to be incorporated into treatment algorithms. In this report, we review HIV diagnostics in use and in development, the main players involved in the development of novel HIV diagnostics, and the impact these tests will have on HIV drug development in the United States. Please note: the PDF e-mail from publisher version of this report is for a global site license. |
Related Markets
Disease Management Reports
- 6th Asian Pacific Congress of Heart Failure (APCHF) - Post-Conference Review and Analysis
- Global Infectious Disease Treatment Market 2011-2014
- Analysis of the European Thrombosis Therapeutics Market
- Market Access in the United States: An Uncertain Outlook
- Optimizing Treatment for Bone Metastases in Patients with Advanced Cancers
